CONMED Corporation (CNMD) Stock Analysis

CONMED Corporation (CNMD) Stock Analysis — AI Research | MarketCI

CNMD

Market Closed

CONMED Corporation

NYSEHealthcare Medical - Devices

3.90K employees

CEO: Patrick J. Beyer

Founded: 1987

$42.68

+$0.00(+NaN%)

Market Cap

1.29B

Beta

0.93

52W Range

N/A

Dividend Yield

1.87%

Overview Forecasts Fundamental Market Sentiment Valuation Ownership

CNMD Price Chart

Historical price performance

Loading MCI price data...

MarketCI Investment Signals

AI-synthesized investment signal for CNMD built from valuation, fundamentals, sentiment, and risk models

Investment Signal

Hold

Pass %

57.14%

Score

4/7

Fair Value Estimate

Cash flow analysis • Multiple methods

$117.28

AI Price Target

Machine learning • Price prediction

$36.25

Market Sentiment

News & social media analysis

0.00

Value Investor Price

Classic value analysis

$18.40

Financial Health

Bankruptcy risk assessment

1.88

Quality Score

Financial strength rating

9.00

AI Investment Grade

Deep analysis of filings & news

72.00

Key Investment Highlights

Important factors affecting CNMD investment thesis

Due Diligence Analysis

Investment criteria assessment and scoring

Overall Assessment

67.44% Good

Conditions Met

29.00/43.00

Due Diligence Score

67.44%

Due Diligence Conditions

Investment analysis conditions and results


	Pass
	Pass
	Pass
	Pass
	Pass
	Pass

Showing 1 to 6 of 46 conditions